logo-loader
viewCann Global Ltd

Cann Global re-lists and starts afresh in medical marijuana space

Cann Global re-lists and starts afresh in medical marijuana space

Cann Global Ltd (ASX:CGB) managing director Sholom Feldman updates Proactive Investors on the company’s exciting transformation from a mining company into the medical cannabis space.

The company has recently been relisted on the Australian Stock Exchange and has raised revenue to help support the new focus, strategy and growth.

Impressive results are already being seen in the company’s hemp food division, medical research with a Israeli University and a joint venture with international health and wellness company Pharmacan.

Quick facts: Cann Global Ltd

Price: 0.0125 AUD

ASX:CGB
Market: ASX
Market Cap: $40.34 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Search Minerals hoping to use patented technology in...

Search Minerals Inc. (CVE: SMY) President and CEO Greg Andrews joined Steve Darling from Proactive in Vancouver to discuss the company that if focuses on the exploration and development of the Critical Rare Earth Element District in Southeastern Labrador, Canada.  Andrews talks about...

4 hours, 39 minutes ago

2 min read